Patients who qualify receive a prescription for compounded or brand-name GLP-1 medication, depending on availability and clinical recommendation
At Kairos Rejuvenation, we are excited to offer three cutting-edge peptidesBPC-157, GHK-Cu, and TB-500designed to support healing, reduce inflammation, and enhance overall well-being
Greater weight loss Weight loss differs dramatically between the two medications
Understanding insurance drug coverage Insurance plans have a formulary, or preferred drug list (PDL), that shows which drugs are covered by that plan
In this analysis, we included the negative allosteric modulators NNC0640 (PDB: 5VEX) and PF-06372222 (PDB: 6KJV), the peptide agonists GLP-1 (7-36) (PDB: 6X18), exenatide (PDB: 7LLL) and semaglutide (PDB: 7KI0) as well as the small molecule agonist danuglipron (PDB: 6X1A) (Supplementary Data 1)